Compounds > ambuphylline
Page last updated: 2024-12-06

ambuphylline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

ambuphylline: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID21850
CHEMBL ID2104089
SCHEMBL ID355316
MeSH IDM0049079

Synonyms (33)

Synonym
bufylline (ban)
5634-34-4
D02884
ambuphylline (usan)
butaphyllamine (tn)
theophylline compound with 2-amino-2-methyl-1-propanol (1:1)
buthoid
ambuphylline [usan]
einecs 227-077-5
theophylline aminoisobutanol
bufylline
ambuphylline
3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione, compound with 2-amino-2-methylpropan-1-ol (1:1)
butaphyllamine
unii-vou5v0b772
vou5v0b772 ,
ambuphylline [mi]
bufylline [mart.]
ambuphylline [who-dd]
CHEMBL2104089
AKOS016340427
SCHEMBL355316
KS-1324
SEIRRUDMPNNSCY-UHFFFAOYSA-N
DTXSID60204880
theophylline-2-aminoisobutanol
Q4741993
DB13812
1,3-dimethyl-1h-purine-2,6(3h,7h)-dione compound with 2-amino-2-methylpropan-1-ol (1:1)
2-amino-2-methylpropan-1-ol;1,3-dimethyl-7h-purine-2,6-dione
1,3-dimethyl-2,3,6,7-tetrahydro-1h-purine-2,6-dione; 2-amino-2-methylpropan-1-ol
CS-0026398
HY-105647
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
1-butanol
1-Butanol: A four carbon linear hydrocarbon that has a hydroxy group at position 1.. butan-1-ol : A primary alcohol that is butane in which a hydrogen of one of the methyl groups is substituted by a hydroxy group. It it produced in small amounts in humans by the gut microbes.		2.3320alkyl alcohol;
primary alcohol;
short-chain primary fatty alcohol		human metabolite;
mouse metabolite;
protic solvent
theophylline
[no description available]		3.1860dimethylxanthineadenosine receptor antagonist;
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
drug metabolite;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
fungal metabolite;
human blood serum metabolite;
immunomodulator;
muscle relaxant;
vasodilator agent
aminophylline
Aminophylline: A drug combination that contains THEOPHYLLINE and ethylenediamine. It is more soluble in water than theophylline but has similar pharmacologic actions. It's most common use is in bronchial asthma, but it has been investigated for several other applications.. aminophylline : A mixture comprising of theophylline and ethylenediamine in a 2:1 ratio.		1.9210mixturebronchodilator agent;
cardiotonic drug
ConditionIndicatedRelationship StrengthStudiesTrials
Cardiac Diseases
[description not available]		01.9210
Cardiac Failure
[description not available]		02.8440
Heart Diseases
Pathological conditions involving the HEART including its structural and functional abnormalities.		01.9210
Heart Failure
A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.		02.8440